ECG trades 2.6% above Wall Street's consensus target of $153.60.
Last 12 months price action with 12-month analyst target path
The base valuation assumes ECG achieves its forward estimates and maintains a stable P/E multiple of 34.9x. This scenario reflects the blended consensus of 6 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 22, 2026, Everus Construction Group, Inc. (ECG) has a Wall Street consensus price target of $153.60, based on estimates from 6 covering analysts. With the stock currently trading at $157.71, this represents a potential downside of -2.6%. The company has a market capitalization of $8.05B.
Analyst price targets range from a low of $115.00 to a high of $180.00, representing a 42% spread in expectations. The median target of $160.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 4 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, ECG trades at a trailing P/E of 39.9x and forward P/E of 34.9x. Analysts expect EPS to grow +3.7% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $180.38, with bear and bull scenarios of $113.64 and $237.67 respectively. Model confidence stands at 50/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
PWRQuanta Services, Inc. | $105.4B | $702.25 | $674.27 | -4.0% | Buy | 50.2x | 36 |
MTZMasTec, Inc. | $29.9B | $379.66 | $416.73 | +9.8% | Buy | 43.0x | 36 |
PRIMPrimoris Services Corporation | $5.5B | $101.30 | $152.78 | +50.8% | Buy | 20.9x | 24 |
MYRGMYR Group Inc. | $7.2B | $461.10 | $412.67 | -10.5% | Hold | 40.3x | 21 |
WLDNWilldan Group, Inc. | $1.3B | $89.00 | $117.50 | +32.0% | Buy | 21.6x | 7 |
IESCIES Holdings, Inc. | $14.2B | $712.39 | $458.00 | -35.7% | Hold | 36.2x | 1 |
EMEEMCOR Group, Inc. | $37.3B | $836.59 | $987.67 | +18.1% | Buy | 28.5x | 13 |
AGXArgan, Inc. | $10.4B | $738.85 | $559.00 | -24.3% | Buy | 61.1x | 7 |
DYDycom Industries, Inc. | $13.7B | $456.65 | $603.63 | +32.2% | Buy | 27.5x | 22 |
GLDDGreat Lakes Dredge & Dock Corporation | $1.1B | $17.00 | — | — | Buy | 15.4x | 7 |
Quick answers to the most common questions about buying ECG stock.
Wall Street's consensus price target for ECG is $153.6, -2.6% from its current price of $157.71. The below-market target from 6 analysts suggests limited near-term appreciation.
ECG has a consensus rating of "Buy" based on 6 Wall Street analysts. The rating breakdown is predominantly bullish, with 4 Buy/Strong Buy ratings. The consensus 12-month price target of $153.6 implies -2.6% downside from current levels.
ECG trades at a forward P/E of 34.853x, representing a moderate valuation. With analysts targeting $153.6 (-2.6% implied move), the stock appears close to fair value.
The most bullish Wall Street analyst has a price target of $180 for ECG, while the most conservative target is $115. The consensus of $153.6 represents the median expectation. Our quantitative valuation model projects a bull case target of $238 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
ECG is moderately covered, with 6 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 2 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ECG stock forecast based on 6 Wall Street analysts shows a consensus price target of $153.6, with estimates ranging from $115 (bear case) to $180 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $180, with bear/bull scenarios of $114/$238.
Our quantitative valuation model calculates ECG's fair value at $180 (base case), with a bear case of $114 and bull case of $238. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 50/100.
ECG trades at a forward P/E ratio of 34.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 39.9x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on ECG, with 0 Sell ratings and a price target of $153.6 (-2.6% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ECG analyst price targets range from $115 to $180, a 42% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $153.6 consensus represents the middle ground. Our model's $114-$238 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.